Author

Νικόλαος Νικολάου

AstraZeneca (United Kingdom)ORCID 0000-0001-8453-7574Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Approach:machine learning (classical)· 2 Assay:bulk RNA-seq· 1 Assay:imaging· 1

Frequent Co-Authors

Harish RaviPrakashiD· 2 shared Domingo Salazar· 1 shared Etai JacobiD· 1 shared Ignacio Gonzalez-García· 1 shared Joachim Reischl· 1 shared José Domingo Salazar· 1 shared Kedar A. PatwardhaniD· 1 shared Miguel Gonçalves· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioinformatics

Harish RaviPrakashORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioinformaticsFrontiers in ImmunologyPeer-reviewedJun 10, 2024

Towards a Survival Risk Prediction Model for Metastatic NSCLC Patients on Durvalumab Using Whole-Lung CT Radiomics

Kedar A. Patwardhan, Harish RaviPrakash, Νικόλαος Νικολάου…·Joachim Reischl

This study develops machine learning models using CT radiomics and clinical data to predict survival in metastatic NSCLC patients on durvalumab, showing improved accuracy compared to PD-L1 status.

3 citations

humanimaging

𝕏 PostBluesky

BioinformaticsbioRxivPreprintJan 8, 2024

Quantifying the advantage of multimodal data fusion for survival prediction in cancer patients

Νικόλαος Νικολάου, Domingo Salazar, Harish RaviPrakash…·Etai Jacob

This study develops a multimodal fusion pipeline that improves survival prediction in cancer patients by outperforming unimodal models using The Cancer Genome Atlas data.

7 citations

humanbulk RNA-seq

𝕏 PostBluesky